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ABSTRACT The human diarrheal pathogens Campylobacter jejuni and Campylobac-
ter coli interfere with host innate immune signaling by different means, and their
ﬂagellins, FlaA and FlaB, have a low intrinsic property to activate the innate immune
receptor Toll-like receptor 5 (TLR5). We have investigated here the hypothesis that
the unusual secreted, ﬂagellin-like molecule FlaC present in C. jejuni, C. coli, and
other Campylobacterales might activate cells via TLR5 and interact with TLR5. FlaC
shows striking sequence identity in its D1 domains to TLR5-activating ﬂagellins of
other bacteria, such as Salmonella, but not to nonstimulating Campylobacter ﬂagel-
lins. We overexpressed and puriﬁed FlaC and tested its immunostimulatory proper-
ties on cells of human and chicken origin. Treatment of cells with highly puriﬁed
FlaC resulted in p38 activation. FlaC directly interacted with TLR5. Preincubation with
FlaC decreased the responsiveness of chicken and human macrophage-like cells to-
ward the bacterial TLR4 agonist lipopolysaccharide (LPS), suggesting that FlaC medi-
ates cross-tolerance. C. jejuni ﬂaC mutants induced an increase of cell responses in
comparison to those of the wild type, which was suppressed by genetic comple-
mentation. Supplementing excess puriﬁed FlaC likewise reduced the cellular re-
sponse to C. jejuni. In vivo, the administration of ultrapure FlaC led to a decrease in
cecal interleukin 1 (IL-1) expression and a signiﬁcant change of the cecal microbi-
ota in chickens. We propose that Campylobacter spp. have evolved a novel type of
secreted immunostimulatory ﬂagellin-like effector in order to speciﬁcally modulate
host responses, for example toward other pattern recognition receptor (PRR) ligands,
such as LPS.
IMPORTANCE Flagellins not only are important for bacterial motility but are major
bacterial proteins that can modulate host responses via Toll-like receptor 5 (TLR5) or
other pattern recognition receptors. Campylobacterales colonizing the intestinal
tracts of different host species harbor a gene coding for an unusual ﬂagellin, FlaC,
that is not involved in motility but is secreted and possesses a chimeric amino acid
sequence composed of TLR5-activating and non-TLR5-activating ﬂagellin sequences.
Campylobacter jejuni FlaC activates cells to increase in cytokine expression in chicken
and human cells, promotes cross-tolerance to TLR4 ligands, and alters chicken cecal
microbiota. We propose that FlaC is a secreted effector ﬂagellin that has speciﬁcally
evolved to modulate the immune response in the intestinal tract in the presence of
the resident microbiota and may contribute to bacterial persistence. The results also
strengthen the role of the ﬂagellar type III apparatus as a functional secretion sys-
tem for bacterial effector proteins.
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Campylobacter jejuni and Campylobacter coli are bacterial pathogens which colonizedifferent hosts. While they generally cause acute, self-limiting intestinal disease,
such as diarrhea, in humans, they persist chronically in several different animal species,
including avian and mammalian hosts. The basis of the interaction with their hosts, the
causality of virulence in humans, and the differential outcomes of the infection or
colonization of different mammalian and avian hosts are incompletely understood.
C. jejuni is highly motile due to bipolar ﬂagella, a characteristic which plays an
important role in colonization of the host (1–3). Based on whole-genome information
and functional characterization, the ﬂagellum is predicted to have a conserved com-
position of basal body, hook, and ﬁlament portions. The ﬂagellar ﬁlament is composed
of two ﬂagellins, FlaA and FlaB, which share high amino acid identity between each
other (4). In addition, the ﬂagellar type III secretion system (T3SS) of C. jejuni is also
involved in the secretion of several nonﬂagellar proteins with roles in virulence (5).
Several putative effector proteins, such as Cia proteins, FlaC, Cj0977, and FspA, are
secreted through the ﬂagellar T3SS of C. jejuni and inﬂuence the interaction with the
host environment (5–8).
Canonical ﬂagellin molecules, such as Salmonella FliC, are recognized by the cellular
innate immune receptor, Toll-like receptor 5 (TLR5), of eukaryotic cells (9, 10). Two
major conserved regions of ﬂagellin, which also contribute to ﬁlament formation and
motility, are responsible for TLR5 recognition (11, 12). Recently, Yoon et al. (12)
crystallized the exodomain of TLR5 from zebraﬁsh in a complex with FliC ﬂagellin of
Salmonella enterica serovar Typhimurium, known as a strong activating ligand of TLR5
(12). This study provided the ﬁrst structural details for the interaction of TLR5 with
ﬂagellin. Two primary binding interfaces, A and B, within the folded D1 domains of the
FliC antiparallel helices were deﬁned to be involved in the speciﬁc binding of TLR5.
Interestingly, several studies demonstrated that ﬂagellins of Alpha- and Epsilonpro-
teobacteria, including C. jejuni and Helicobacter pylori, have a low intrinsic propensity to
activate TLR5 (13–16), suggesting that these pathogens evolved an important mecha-
nism to escape from the innate immune response of the host without compromising
motility. The three-dimensional (3-D) structure of the ﬂagellin multimer, the conforma-
tion of the alpha-helical ﬂagellin D1 and D2 monomeric domains, and the surface-
exposed epitopes in ﬂagellin multimers are predicted to differ between the activating
(Salmonella) and nonactivating (Campylobacter) ﬂagellin variants (17). In general, TLR5
recognition of pathogenic and nonpathogenic bacteria seems to play a crucial role, in
particular in the intestinal tract, as demonstrated by several studies using TLR5-
deﬁcient mice (18, 19; for a review, see reference 20). On one hand, TLR5 signaling is
involved in the maintenance of immune homeostasis between the commensal micro-
biota and the host immune system (21), and on the other hand, it appears to play an
important role in the defense against acute enterobacterial infection (19, 22, 23).
Due to the zoonotic potential of C. jejuni and its ability to colonize different hosts,
the possible species-speciﬁc recognition of C. jejuni’s microbe-associated molecular
patterns (MAMPs) by TLRs and other pattern recognition receptors (PRRs) should be
considered while analyzing its interaction with different hosts. Several reports have
shown the activation of NF-B and mitogen-activated protein kinases (MAPKs) and the
induction of different cytokines upon C. jejuni infection in both human and chicken
cells, suggesting that C. jejuni is able to trigger innate immune responses in different
hosts (16, 24–29). On the other hand, the outcomes of activation by C. jejuni vary
between different host species. Indeed, species-speciﬁc properties of TLRs and their
recognition have already been described. Human, chicken, and mouse TLR5 can
recognize ﬂagellin differentially (30, 31), and also chicken TLR4 appears to exhibit
species-speciﬁc responses to bacterial lipopolysaccharide (LPS) or lipo-oligosaccharide
(32).
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The aim of the present work was to address the function of the unusual ﬂagellin-like
protein FlaC of C. jejuni. Until now, only one study has analyzed FlaC functionally, and
it demonstrated that FlaC secretion depends on the ﬂagellar apparatus (7). Additionally,
the binding of FlaC to epithelial cells and its inﬂuence on cell invasion was previously
demonstrated; however, no precise function could be attributed to this protein so far.
Due to its high amino acid similarity with other ﬂagellins, we hypothesized that FlaC
may be able to interact with TLR5 and may thereby modulate host interaction and the
innate immune response.
We report here that FlaC is conserved in various intestinal nonsheathed Campylo-
bacter and Helicobacter species. Puriﬁed C. jejuni FlaC was tested for immunostimulatory
properties on different cell types. FlaC activated cells, interacted with TLR5 in vitro, and
inﬂuenced the responsiveness of chicken and human macrophage-like cells toward
subsequent exposure to bacterial TLR4 ligands. We propose that Campylobacter spp.
and related bacteria have evolved a novel type of secreted ﬂagellin-like effector protein
in order to modulate host responses and bacterial persistence.
RESULTS
In silico comparison of C. jejuni FlaC with other ﬂagellin molecules—evidence for
a chimeric amino acid sequence. The gene ﬂaC is conserved within the species
C. jejuni. In order to identify potential FlaC orthologues in other Campylobacter species,
we performed a BLAST search with C. jejuni FlaC. We found the protein to be conserved
in eight other Campylobacter species (Table 1; see Fig. S1 and S2 in the supplemental
material). An extended search for FlaC orthologues in all currently available genomes
of different Campylobacter species revealed three aﬂagellated species, C. gracilis,
C. hominis, and C. ureolyticus, where the FlaC open reading frame seems to be lacking.
Interestingly, FlaC appears not to be restricted to the genus Campylobacter, since three
intestinal Helicobacter species without ﬂagellar sheaths and a commensal epsilonpro-
teobacterium of the ruminant stomach, Wolinella succinogenes, possess clear FlaC
orthologues, exhibiting 43% to 47% amino acid identity with C. jejuni FlaC (Table 1).
Comparative analysis of the ﬂaC gene context in different ﬂaC-containing genomes
revealed that genomes of more closely related Campylobacter species, e.g., C. jejuni,
C. coli, and C. fetus, share the same ﬂaC genetic neighborhood but that less closely
related species seem to harbor ﬂaC in a different genomic context (Fig. S1 and S3). ﬂaC
gene sequences between different C. jejuni strains of different phylogenetic lineages
showed3.6% interstrain nucleotide polymorphisms (96.4% identical nucleotides) in
both synonymous and nonsynonymous nucleotide sites (the ratio of the number of
nonsynonymous substitutions to the number of synonymous substitutions [Ka/Ks] was
3.5) (data not shown).
We generated an amino acid alignment of all currently identiﬁed FlaC orthologues
with Salmonella enterica FliC, representing canonical TLR5-activating ﬂagellin, and
Campylobacter FlaA, representing non-TLR5-activating ﬂagellin (13–16) (Fig. 1). In com-
TABLE 1 C. jejuni FlaC orthologues in Campylobacter spp. and other Campylobacteralesa
Species and strain name
(for genomic information) Species host(s)/niche(s)
% amino acid identity
to C. jejuni FlaC
C. coli RM2228 Cattle, chicken/intestinal tract 95
Campylobacter upsaliensis JV21 Cat, dog/intestinal tract 84
Campylobacter lari RM2100 Cattle, chicken, wild birds/intestinal tract 68
Campylobacter showae CSUSNWCD Dog, human/intestinal tract 50
Campylobacter rectus RM3267 Dog/intestinal tract 49
C. fetus subsp. fetus 82.40 Diverse/intestinal tract, urogenital tract 49
Campylobacter curvus 525.92 Dog/intestinal tract 48
H. pullorum MIT 98-5489 Chicken, human/intestinal tract 47
H. canadensis MIT 98-5491 Wild birds, human/intestinal tract 45
H. winghamensis ATCC BAA 430 Human/intestinal tract 44
W. succinogenes DSM 1740 Cattle/intestinal tract 43
C. concisus 13826 Cat, dog, human/intestinal tract 39
aNone of the species had ﬂagellar sheaths.
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parison to other bacterial ﬂagellins, Campylobacter FlaC shows a striking amino acid
sequence similarity in crucial residues of its D1 domains to TLR5-stimulating ﬂagellins
of other bacteria, such as Salmonella. In particular, the D1 region comprising amino
acids 89 to 96 of FliC within its primary interface B (12), which is important for TLR5
binding and activation (11, 12), appears to be conserved in Campylobacter FlaC (Fig. 1).
On the other hand, some other amino acids within the FlaC D1 domains are more
similar to the TLR5-nonstimulating domains that were previously described for the
Campylobacterales Campylobacter and Helicobacter (13–16, 33), suggesting a chimeric
amino acid sequence of FlaC between TLR5-stimulating and non-TLR5-stimulating
ﬂagellins (Fig. 1).
Characterization of C. jejuni ﬂaC mutants and bacterial subcellular local-
ization of FlaC in C. jejuni 11168 and 81-176. In order to characterize the function
and localization of FlaC in the bacterial context, we generated C. jejuni mutants lacking
FIG 1 ClustalOmega alignment of FlaC protein sequences. C. jejuni (Camje) FlaA (pink, a representative of non-TLR5-stimulatory flagellins), S. enterica
(Salen) FliC (green, a paradigm for a TLR5-activating flagellin), and FlaC protein sequences of various Epsilonproteobacteria were aligned with
ClustalOmega (http://www.ebi.ac.uk/Tools/msa/clustalo) and visualized in GeneDoc (https://www.psc.edu/index.php/user-resources/software/genedoc).
The locations of the D0 and D1 domains are indicated above the sequences. Residues of FliC involved in TLR5 binding and activation are shaded in gray
(primary interface A) and in black (primary interface B) (according to reference 12). Residues of FlaC identical to those in C. jejuni FlaA or S. enterica FliC
are colored accordingly in pink or green, respectively. A consensus score is shown underneath the alignment. Only flagellin sequence domains D0 and
D1 present in FlaC are depicted; since the D2 and D3 domains are largely absent from FlaC orthologues, these domains have been omitted from the
alignment.
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FlaC in different strains by allelic-exchange mutagenesis. These mutants of strains
11168 and 81-176 were ﬁrst analyzed with regard to their motility in comparison to that
of their respective wild-type bacteria in motility agar plates (Fig. 2A). All bacteria
showed comparable levels of positive motility after 2 days of incubation, indicating that
the absence of FlaC has no perceptible impact on bacterial motility. Swimming assays
in liquid or assays for bioﬁlm formation did not reveal differences either (data not
shown). These ﬁndings are in agreement with results previously published by Song
et al. for a nonrelated C. jejuni strain, TGH9011 (7).
Western blot analyses of whole bacterial lysates and different fractions of C. jejuni
wild-type and ﬂaC mutants using anti-FlaC antiserum (see Materials and Methods and
Fig. 2B) revealed that FlaC has a molecular mass of about 28 kDa, with minor mass
variation between native FlaCs of the two strains 11168 and 81-176. FlaC was present
in the soluble and the insoluble fractions of the bacterial lysates, and a small FlaC
fraction could be detected in the surface-associated protein fractions. A large propor-
tion of the protein (90%) was identiﬁed in the secreted protein fraction, corroborating
previously published results (7).
Antibody responses to C. jejuni FlaC in infected chickens suggest its
expression in vivo. Samples of 22 chickens which differed in age, breed, and
husbandry conditions (see Table S1 in the supplemental material) were analyzed for an
infection with Campylobacter. We plated cloacal swabs on blood agar and screened the
recovered bacteria visually and microscopically for their morphology. Furthermore, we
clone-puriﬁed potential Campylobacter colonies from the swabs and analyzed them
using PCR with universal Campylobacter primers (not shown), conﬁrming Campylobac-
ter identity. Sera of 14 Campylobacter-infected chickens were subsequently tested in a
Western blot analysis against puriﬁed recombinant FlaC. Although the intensities of the
signals varied depending on the individual bird, each serum from a Campylobacter-
positive chicken was reactive against recombinant puriﬁed FlaC of C. jejuni, even at a
high serum dilution of 1:10,000 (Fig. 3A). In contrast, sera from Campylobacter-free
chickens (speciﬁc-pathogen-free [SPF] animals 20 to 22) showed no reactivity to FlaC
(Fig. 3A). These results may support the possibility that FlaC is expressed in vivo in
chicken. In order to verify directly whether FlaC is expressed in vivo in the chicken
FIG 2 Characterization of C. jejuni flaC mutants and subcellular localization of FlaC. (A) Motility of the C. jejuni
11168 and 81-176 wild types (wt) and two corresponding flaC mutants (clone 1 and 2 [c1 and c2, respectively])
of each strain. A representative soft-agar motility plate from at least three independent assays shows the
motility areas of all bacterial strains (swim diameter of ca. 10 mm) after 2 days of incubation at 37°C (scale bar,
10 mm). Corresponding motility-negative controls of C. jejuni (flgR mutant) always exhibited a swim halo
diameter of <1 mm under the same conditions, while flaC-complemented bacteria reproducibly had a swim
diameter similar to that of the wild type and flaC mutant (not shown). (B to D) Subcellular localization of FlaC
in C. jejuni bacterial fractions. Comparative Western blot analyses of whole-cell lysates and different fractions
of C. jejuni 11168 and 81-176 wild-type and flaC-mutants grown under microaerobic conditions were per-
formed using polyclonal rabbit FlaC antiserum (dilution, 1:5,000). (B) S, soluble bacterial fraction; IS, insoluble
bacterial fraction. (C) Surface/flagellar proteins. (D) Secreted proteins. Expression of FlaC was also investigated
under anaerobic conditions. Western blot analyses of whole-cell lysates and different fractions of wild-type and
flaC mutants grown under anaerobic conditions yielded comparable results (not shown). Our estimate from
comparative Western blots was that approximately 2 g of FlaC was secreted per 109 bacteria, and 100 to
200 ng of cell-bound FlaC was present in the same number of bacteria.
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cecum, quantitative real-time PCR was performed on cecal tissues from experimentally
infected chickens. The ﬂaC transcript was indeed present in chicken cecal tissue
(Fig. 3B). The FlaC-recognizing chicken sera also detected the C. jejuni major ﬂagellin,
FlaA, in bacterial fractions (not shown).
Puriﬁed C. jejuni FlaC activates human and chicken cells. For further func-
tional characterization, C. jejuni FlaC was expressed in Escherichia coli and puriﬁed
under denaturing conditions using metal afﬁnity chromatography (13). The puriﬁed
protein was then dialyzed several times and gel eluted to render it highly pure and free
from contamination with LPS, as previously established (see Materials and Methods and
reference 13). For the investigation of the proposed host cell stimulatory properties
of FlaC, we coincubated highly puriﬁed C. jejuni FlaC with human and chicken
macrophage-like and epithelial cell lines and determined cytokine release into the
supernatants. Flagellins acting via TLR5 have been shown to induce interleukin 8 (IL-8)
secretion in human cells (34). Unexpectedly, enzyme-linked immunosorbent assay
(ELISA) measurements using supernatants of human HEK293T, THP-1, and colon intes-
tinal epithelial Lovo cells did not reveal signiﬁcantly increased secreted IL-8 or IL-1
levels after 4 to 5 h of coincubation with highly pure FlaC (not shown), although these
cells secreted cytokines in response to Salmonella FliC used as a control.
Since ﬂagellins can activate several different and mutually overlapping signaling
pathways (35–37), e.g., those mediated by TLR5 and inﬂammasomes, we performed
further activation analyses in order to test stimulating properties of C. jejuni FlaC
downstream of TLRs, at the level of transcription factor NF-B and mitogen-activated
protein kinases (MAPKs). MAPK p38 and extracellular signal-regulated kinase (ERK) have
FIG 3 Immune response in infected chickens to C. jejuni FlaC. (A) Adaptive immune response to
recombinant C. jejuni FlaC in Campylobacter-infected chickens. Western blot analyses were per-
formed to investigate and compare the reactivities of whole sera from Campylobacter-infected (lanes
1 to 19) and noninfected (lanes 20 to 22) chickens. Chicken sera were used at a dilution of 1:10,000
and detected with horseradish-peroxidase-coupled anti-chicken antibody. (B) In vivo expression of
flaC in chicken cecal tissue. Transcript levels of flaC were determined by using quantitative RT-PCR
of total RNA extracted from the ceca of five chickens which had been experimentally infected with
C. jejuni strain RB922 (48). The amounts of specific flaC cDNA (in picograms) were normalized to
C. jejuni 16S rRNA gene amounts determined in each animal.
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been described to be strongly activated by ﬂagellins, e.g., the canonical TLR5 ligand
Salmonella enterica FliC (34, 38). To investigate whether C. jejuni FlaC is able to activate
the MAPK cascade, we coincubated human and chicken cells with highly puriﬁed FlaC
and analyzed p38 and ERK phosphorylation in Western blots. Highly pure FlaC led to an
enhanced phosphorylation of p38 (Fig. 4A) and ERK (data not shown) in human and
chicken cells at different time points of coincubation (2 h, 4 h), as did the control
protein FliC. For the analysis of NF-B activation, human THP-1, Lovo, and chicken
HD-11 cells stably transfected with an NF-B-dependent luciferase reporter construct
were incubated with highly pure recombinant C. jejuni FlaC or with highly pure
recombinant Salmonella FliC as a positive control (Fig. 4B and C). The results were
quantitated using luciferase measurements. Chicken HD-11 and human THP-1 cells
showed signiﬁcantly enhanced NF-B activation levels after coincubation with puriﬁed
FliC (Fig. 4C). FlaC, like the mock control, did not signiﬁcantly enhance NF-kB-
dependent luciferase in human or chicken cells (Fig. 4B and C), whereas Salmonella FliC
activated cells in a concentration-dependent manner, as expected (shown for Lovo cells
in Fig. 4B).
A stimulated TLR5 signaling cascade by bacterial ﬂagellin leads to the expression of
numerous proinﬂammatory cytokines (35). Since no signiﬁcantly elevated IL-8 secretion
could be identiﬁed after exposure of different human cell types (THP-1, Lovo, HEK293
cells) (data not shown) to puriﬁed FlaC, we assayed TLR5 downstream signaling with
regard to transcriptional activation of cytokine genes. For this purpose, we coincubated
human (THP-1) and chicken (HD-11) macrophage-like cells with puriﬁed FlaC or with
FliC as a positive control for 2 h. Quantitative analysis via real-time PCR revealed
signiﬁcantly enhanced transcript amounts of human IL-1 (hIL-1) (Fig. 4D), hIL-8
(Fig. 4E), and hIL-10 (Fig. 4F) in the human cells. In chicken cells, we determined even
10-fold-increased transcript levels of chicken IL-1 (chIL-1) (Fig. 4G), chIL-8 (Fig. 4H),
and the chicken monocyte chemotactic cytokine chK203 (Fig. 4I) (39) after a 2-h
exposure to puriﬁed FlaC, similar to what occurred with the positive control, FliC. As an
additional control, to verify TLR5-dependent cell activation by FlaC, we used HEK293
cells transiently transfected with human TLR5 (hTLR5) expression plasmid in accordance
with previously published controls (33). The transiently transfected hTLR5 cells showed
a slight but signiﬁcant induction of IL-8 secretion when coincubated with FlaC (Fig. S4),
while a strong, signiﬁcant induction was demonstrated with Salmonella FliC. However,
when cytokine mRNAs were quantitated in the hTLR5-transfected cells, we again noted
a signiﬁcant induction of IL-10 mRNA by both FlaC (6-fold) and FliC (4-fold) in com-
parison to levels of induction in the hTLR5 control (data not shown).
Recombinant puriﬁed FlaC is able to bind to cells and to physically asso-
ciate with TLR5. In order to test whether FlaC can bind to cells, we added gel-
extracted highly pure recombinant C. jejuni FlaC (see Materials and Methods) to live
chicken HD-11 or human HEK293T cells. Cells were coincubated with FlaC for 1 h,
washed extensively, lysed, and fractionated. The lysate fractions (soluble and insoluble)
were analyzed on SDS gels for FlaC binding. We detected FlaC binding both to human
and to chicken cells, predominantly in the insoluble cell fractions containing membrane
constituents (see Fig. S5 in the supplemental material). Binding of the positive-control
protein Salmonella FliC was also demonstrated with both cell lines (Fig. S5A and B).
While full-length FliC was recovered in HEK293 cell fractions (Fig. S5A), in the case of
chicken macrophage-like HD-11 cells, only a FliC band of lower molecular mass,
probably representing a processed form of FliC, could be identiﬁed (Fig. S5B). Subse-
quently, we tested for a proposed direct physical interaction of FlaC with TLR5 using a
pulldown approach against the 6His tag of recombinant FlaC. For this purpose, we
used precleared lysates of HEK293T cells that had been transiently transfected with
TLR5 expression plasmid, expressing chicken or human TLR5 (11, 13), or with the
corresponding empty vector. These lysates were incubated to interact with puriﬁed,
6His-tagged FlaC. We noted a direct in vitro interaction of FlaC with hTLR5 in these
assays (Fig. 5). chTR5 was also pulled down with FlaC; however, the chTLR5 control also
slightly bound to the afﬁnity beads in the absence of FlaC. Modeling the structure of
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FIG 4 Effect of purified C. jejuni FlaC on human and chicken cell signal transduction. (A) p38 MAP kinase phosphorylation in human
Lovo_Luc, THP-1_Luc, HEK293T, and chicken HD-11 cells was analyzed by Western immunoblotting after coincubation of the cell lines
with ultrapure recombinant Salmonella FliC (100 ng) or ultrapure recombinant C. jejuni FlaC (200 ng) for 4 h (see Materials and
Methods). Densitometry of P-p38 band intensities was performed, and results were normalized against those for the respective p38
signal and the actin loading control band in each lane. Normalized intensity values indicated that for all 3 cell lines, P-p38 was at
least 5-fold enhanced by FlaC over levels in the mock-incubated control. (B) Analysis of the concentration-dependent response of
Lovo cells, stably transfected with an NF-B luciferase reporter gene, toward Salmonella FliC (positive control) or recombinant
C. jejuni FlaC. (C) HD-11, THP-1, and Lovo cells stably transfected with an NF-B luciferase reporter were coincubated with Salmonella
FliC (25 ng) or recombinant C. jejuni FlaC (100 ng) for 3 h in 96-well plates and analyzed for NF-B-driven luciferase expression using
the SteadyGlo luciferase assay. The luciferase activities in panels B and C are given in luminescence values as photon counts per
second (C/s). (D to I) Quantitative RT-PCR of cytokine mRNA induction by C. jejuni FlaC in human and chicken cells. Levels of induction
of hIL-1 (D), hIL-8 (E), and hIL-10 (F) by C. jejuni FlaC and S. Typhimurium FliC in human macrophages (THP-1) and of chIL-1 (G),
chIL-8 (H), and chK203 (I) in chicken macrophages (HD-11) are shown. Both cell types were stimulated for 2 h with recombinant
ultrapure proteins FlaC (500 ng) and FliC (300 ng). Isolated RNA was analyzed by quantitative RT-PCR. Transcript values were
normalized to human or chicken GAPDH values and are presented as fold increases of mRNA levels compared to the level in a
(Continued)
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the TLR5-FlaC heterotetramer according to the recently published TLR5 ectodomain
crystal structure (12) using HexDock (HexServer) (40) proposed a thermodynamically
favorable interaction interface between the two proteins, speciﬁcally at the FlaC D1
domain (Fig. S6). The modeled TLR5-FlaC heterotetramer arrangement has similar
aspects but is not identical to the FliC-D1-TLR5 interface in the published crystal
structure (12).
C. jejuni FlaC antagonizes the activating effect of the TLR4 ligand bacterial
lipopolysaccharide. TLRs cooperate, synergize, and cross talk with each other and
with signaling induced by other pattern recognition receptors, e.g., the cytoplasmic
NOD-like receptor family, in the case of simultaneous or time-shifted stimulation (41,
42). For instance, it was demonstrated that TLR4 is downregulated by pretreating cells
with ligands of other TLRs (43) and that TLR5 is upregulated by TLR1/2-mediated
signaling (44). In addition, cross-tolerance to different TLR ligands, including TLR4, can
be induced by prior TLR stimulation through a TLR downstream microRNA (miRNA)-
mediated silencing mechanism of interleukin-1 receptor-associated kinase (IRAK) mol-
ecules (45–47). In order to investigate the inﬂuence of C. jejuni FlaC on other TLR-
signaling pathways, we performed time-shifted coincubation experiments with
different TLR ligands using stably transfected human THP-1 and chicken HD-11 cells
(Fig. 6A and B). These assays involved a primary activation step and, on the second day,
a secondary stimulation with E. coli ultrapure LPS (TLR4 ligand). As expected, THP-1 cells
showed an enhanced NF-B activation 3 h after primary coincubation with E. coli LPS
and with Salmonella FliC (canonical TLR5 ligand) (Fig. 6A). Puriﬁed FlaC alone slightly
(nonsigniﬁcantly) stimulated NF-B in the initial activation experiment in both cell lines
(Fig. 6A and B). In each case, the activation by all ligands was almost completely
reversed 19 h after the initial coincubation, as expected (Fig. 6A and B). Only cells which
we initially coincubated with LPS showed a slight residual NF-B activation at the 19-h
coincubation time point. Interestingly, preincubation for 19 h with FlaC (primary
stimulus) was able to antagonize the activating effect of bacterial LPS (secondary
stimulus) in these cells to an extent comparable with that of the canonical TLR ligands
FliC and LPS, which were used as controls (Fig. 6A). Similar results were obtained using
chicken HD-11 cells (Fig. 6B). In order to verify whether the inhibition of activation was
not due to a direct competitive effect of FlaC for binding to TLR4, we also carried out
coincubation assays with FlaC and LPS simultaneously. In this setting, FlaC only slightly
inhibited LPS-mediated TLR activation (data not shown). LPS antagonist (polymyxin B)
treatment of cells prevented primary LPS activation and the cross-tolerizing effect by
FlaC (Fig. 6A).
Live C. jejuni bacteria induce differential activation of cells in the presence
or absence of FlaC. As isolated FlaC can activate cells, the question of how this
capacity and the presence of FlaC produced by live bacteria impact the complex
interactions between bacteria and cells remained to be answered. To address this
question, we coincubated live bacteria of two different C. jejuni parental strains, 11168
and 81-176, and their isogenic ﬂaC mutants with THP-1 reporter cells at different
multiplicities of infection (MOI). Cells were differentially activated in a dose-dependent
manner (MOI dependent) by wild-type or ﬂaC bacteria (Fig. 7A) of both strains. At early
time points of coincubation relevant for primary innate immune responses (up to 4 h),
ﬂaCmutants induced signiﬁcantly more NF-kB activation at all tested MOI than the wild
type. The same effect was observed for the induction of IL-8 secretion by live C. jejuni
bacteria in THP-1 cells (Fig. 7B).
In a different setting, we addressed the effect of FlaC more speciﬁcally by
preincubating cells with highly puriﬁed FlaC before the addition of C. jejuni bacterial
lysates. FlaC-supplemented wild-type lysates induced signiﬁcantly less NF-kB acti-
Figure Legend Continued
mock-coincubated control. Mean values and standard deviations from triplicate measurements are shown. Significant P values are
indicated by asterisks (Student’s t test, unpaired, one-sided) as follows: *, 0.01 < P < 0.05; **, 0.001 < P < 0.01; and ***, P < 0.001.
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vation even than the wild-type lysates alone, in particular in chicken HD-11 cells
(Fig. 7D). In contrast, ﬂaC mutant lysates of both C. jejuni strains displayed a
signiﬁcantly increased potency toward inducing NF-B-dependent signaling in
comparison to that of the wild-type lysates (Fig. 7C and D). Both cell lines were
highly responsive to either TLR4 (Fig. 6A and B) or TLR2 (data not shown) ligands,
suggesting that the activation by C. jejuni can be mediated by different bacterial
agonists of Toll-like receptors, which may then be antagonized by FlaC. In compar-
ison to the ﬂaC mutant, a ﬂaC-complemented strain expressing ﬂaC under the
control of its intrinsic promoter inserted into the C. jejuni rdxA gene locus (see
Materials and Methods) was able again to reduce the response of THP-1 and HD-11
macrophage-like cells to C. jejuni whole bacterial lysates to the level induced by the
parental strain or even below that level, an effect signiﬁcantly different from that of
the ﬂaC mutant (Fig. 7E and F).
C. jejuni FlaC acts on the chicken cecal immune response and alters
microbiota composition in the chicken cecum. We designed an experiment to
verify that puriﬁed FlaC is able to act in a potentially homeostatic manner on the
microbiota in the ceca of live chicken. Two groups of 2-week-old SPF chickens that had
been hatched and raised together were separated at the zero time point into two
different cages. One FlaC-treated group received microgram amounts of highly puriﬁed
FlaC (25 g in cell culture-grade phosphate-buffered saline [PBS]) at three different
time points (t 0, t 7 days, t 10 days) by the intracloacal route to the colonic-cecal
junction of the birds. The second group of birds was mock treated with sterile PBS at
the same time points. At 14 days after the ﬁrst treatment, the birds were necropsied
and the cecal tissue was subjected to histopathological assessment, microbiota anal-
ysis, and real-time PCR analysis of chicken cytokine transcript levels in the ceca.
Histopathology assessment showed comparable, low inﬂammatory scores from the
cecal tissues of both groups (data not shown). Comparative microbiota analyses of the
ceca between the two groups of birds revealed signiﬁcant differences in the overall
microbiota compositions (beta-diversity) (for the analysis of molecular variance
[AMOVA] based on Bray-Curtis distances, P was 0.022; for the AMOVA based on Jaccard
distances, P was 0.004) (Fig. 8D). The overall numbers of detected operative taxonomic
units (OTU), their levels of overall diversity, and the abundances of different bacteria at
the family level did not differ signiﬁcantly between the microbiotas of the two groups
(Fig. 8A to C), while single bacterial OTU differed signiﬁcantly between both groups
(Fig. 8 D; Table 2). Of the different chicken cytokines that we quantitated in real-time
PCR (chIL-8, chK60, chK203, chIL-17a, chIL-1), levels of chIL-1 were signiﬁcantly
FIG 5 Interaction of C. jejuni FlaC with TLR5 in vitro. Binding of C. jejuni FlaC to TLR5 was tested by
pulldown assay. Cleared cell lysates from TLR5 plasmid-transfected (hTLR5, human; chTLR5, chicken;
both expressed as a V5-tagged protein fusion) or empty-plasmid-transfected cells were generated
and coincubated with purified C. jejuni 6His-FlaC. Pulldown against the 6His tag fused to FlaC was
performed using Talon Co2 resin. Protein detection on Western blots was performed using rabbit
anti-6His antiserum (diluted 1:1,000; Rockland) for FlaC, and anti-V5 antibody (mouse monoclonal,
1:5,000; Invitrogen) for the detection of hTLR5 and chTLR5 (V5 tagged). The input was cleared cell
lysates of TLR5-V5 plasmid-transfected HEK293T cells that were used for the pulldown. IB, immuno-
blotting; P.D., pulldown.
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different in the cecal tissue of both groups (signiﬁcantly lower in the FlaC-treated
group) (Fig. 8E).
DISCUSSION
C. jejuni and related bacteria have an unusual life style, since they are able to colonize
many different host species (48–50) but thrive quite exclusively in one deﬁned body
niche, for example in the intestinal tracts of various host species. Therefore, it is to be
expected that they (i) possess general features that allow them to modulate the
immune responses of different host species and, at the same time, (ii) exhibit speciﬁc
properties that facilitate the colonization of the intestinal habitat speciﬁcally. The innate
immune response in the mature intestinal tract at the mucosal level is usually charac-
terized by homeostatic downmodulation of TLR4- and TLR2-mediated responses (51–
FIG 6 C. jejuni FlaC antagonizes the activating effect of the TLR4 ligand. Human (THP-1) (A) and
chicken (HD-11) (B) macrophages stably transfected with the NF-B luciferase reporter gene were
coincubated with recombinant C. jejuni FlaC (100 ng), Salmonella FliC (50 ng), or E. coli LPS (25 ng)
for 3 h, and NF-B activation was measured in a SteadyGlo luciferase assay. Residual activation of the
cells in all wells was determined by a luciferase measurement 19 h after the initial incubation. To
analyze the reactivation potential, cells were preincubated with recombinant C. jejuni FlaC, Salmo-
nella FliC, or E. coli LPS for 19 h and then coincubated with E. coli TLR4 ligand LPS (25 ng). The
resulting reactivation potential of NF-B was measured 3 h after the secondary coincubation step. As
a control for TLR4-specific activity, control wells were preincubated with polymyxin B (10 g/ml) 1 h
before the initial activation, as indicated below the graph. For all measurements, relative luciferase
activity is depicted as the percentage of maximal activation by LPS, which was defined as 100%. ,
addition of substance on day 1;, no addition of substance on day 1; *, addition of E. coli LPS on day
2. Significant P values are indicated by asterisks (Student’s t test, unpaired, two-sided), as follows: ***,
P < 0.001.
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FIG 7 C. jejuni flaC mutants induce increased cell activation in human and chicken cells. (A and B) Comparison of cell activation
of live C. jejuni with the respective flaCmutants of two strains, 11168 and 81-176. (A) Human THP-1 NF-B luciferase reporter cells
were coincubated with live C. jejuni bacteria of strain 11168 or 81-176 (wt) and corresponding isogenic flaC mutants (flaC mut)
at different multiplicities of infection (MOI) for 3 h. NF-B activation was determined using SteadyGlo luciferase substrate. Means
and standard deviations from technical quadruplicates are shown as luciferase activity in counts per second (C/s). (B) IL-8
secretion induced by the live C. jejuni wild type and flaC mutants was measured by IL-8 ELISA. The statistical significance of
differences was determined using Student’s t test (unpaired, one-sided). ***, P < 0.001; **, 0.001 < P < 0.01; *, 0.01 <
P < 0.05. (C and D) Human (THP-1) (C) and chicken (HD-11) (D) NF-B luciferase reporter cell lines were coincubated with cleared
lysate fractions of wild-type bacteria (wt) and corresponding flaC mutants (flaC mut) (100 ng of cleared lysate) of two different
C. jejuni strains (11168, 81-176) for 3 h. For comparison, cells which were preincubated for 1 h with purified FlaC (100 ng) were
(Continued)
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55) and an important continuous functional role of the innate ﬂagellin receptor TLR5
(23). The intestine has several other unique characteristics important for pathogen
colonization, e.g., a high density of resident microbiota of various species, a speciﬁcally
primed immunological environment, and a speciﬁc availability of nutrients that is
inﬂuenced by the microbiota (55). Little is known about how C. jejuni and closely related
intestinal species interact with the innate immune systems of their hosts and with the
major pattern recognition receptors (PRRs) of the TLR and NOD families. Glycans of the
species appear to have modulatory effects (56), and it has been reported that the outer
structural subunits of C. jejuni ﬂagella, in particular the major ﬂagellin FlaA, have a weak
intrinsic ability to activate the innate immune system (15, 16). It has been hypothesized
that the evasion of TLR5-mediated responses by the major Campylobacter ﬂagellin FlaA,
similar to that in the related species Helicobacter pylori (13, 14), may help the bacteria
to achieve chronic infection in certain hosts by limiting the intestinal proinﬂammatory
immune response. In contrast to primarily sterile body sites, each bacterial species
resident in the intestine possesses a differential potential to elicit proinﬂammatory or
homeostatic signaling (55, 57).
We have now identiﬁed a novel function of the C. jejuni ﬂagellin-like secreted
protein FlaC to modulate the host innate immune system. FlaC was previously de-
scribed to be potentially involved in host-pathogen interactions (7), but its effects have
not been known in much detail. FlaC was previously assigned to the group of potential
C. jejuni virulence factors that are secreted with the help of the ﬂagellar type III
secretion system (5, 6). We were initially intrigued by the primary amino acid sequence
of FlaC, which is very closely related to those of other ﬂagellins but lacks most of the
central D2 and D3 portions that are present in all known motility-associated ﬂagellins
of Epsilonproteobacteria (15, 58, 59). Although others had reported before that FlaC was
not involved in the motility functions of C. jejuni ﬂagella, we intensively tested the ﬂaC
mutants generated in two different C. jejuni strains for a loss of motility functions in
tracking assays (not shown) and in motility plate assays. Corroborating previously
published results (7), not the slightest reduction in the motility properties of ﬂaC
mutants could be identiﬁed, suggesting that FlaC is indeed not involved in motility
functions but might serve another, yet-unknown function. With two different C. jejuni
reference strains, we also experimentally conﬁrmed previous results with an unrelated
strain (7), showing that FlaC is predominantly a secreted protein. This further supported
the hypothesis that FlaC does not act primarily in a bacterium-bound fashion and raised
the question of which type of function FlaC could fulﬁll as a secreted protein in the
natural habitat of C. jejuni.
ﬂaC was found to be present in all tested strains of C. jejuni. After a search of
genomic databases, ﬂaC orthologues were clearly identiﬁed in a number of different
Campylobacter species’ genomes, including C. jejuni and C. coli, in W. succinogenes (60),
and in three enterohepatic, ﬂagellated nonsheathed (61–63) Helicobacter species,
H. canadensis, H. pullorum, and H. winghamensis. The ﬂaC-positive species comprise the
newly emerging intestinal human pathogens Campylobacter concisus (64), H. canaden-
sis, H. pullorum, and H. winghamensis (65). Interestingly, ﬂaC was present only in
genomes of Epsilonproteobacteria species not possessing a ﬂagellar sheath, which
suggests that it has speciﬁcally evolved based on its potential to be secreted from the
ﬂagellar T3SS apparatus. Generating amino acid alignments of C. jejuni FlaC with a
Figure Legend Continued
also incubated with soluble fractions of wild-type lysates (100 ng) for 3 h. Luciferase activities were measured in a SteadyGlo
luciferase assay. Mean values and standard deviations of triplicate measurements are depicted as luciferase activities (counts per
second [C/s]). n.s., not significant. (E and F) Complementation of flaC restores the cell activation level by C. jejuni. (E) Human
(THP-1) and (F) chicken (HD-11) macrophages stably transfected for the NF-B luciferase reporter gene were coincubated for 3 h
with soluble lysate fractions (100 ng) of the C. jejuni parental strain (wt), corresponding flaC mutant (flaC mut), and two flaC
complementation clones of strain 81-176 (flaC comp, c1, and c2). NF-B activation was measured using SteadyGlo substrate.
Means and standard deviations from technical quadruplicates are shown as luciferase activity in counts per second [C/s].
Statistical significance was determined using Student’s t test (unpaired, two-sided). Significant P values are indicated by asterisks,
as follows: *, 0.01 < P < 0.05; **, 0.001 < P < 0.01; ***, P < 0.001.
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FIG 8 FlaC has a significant influence on the chicken cecal microbiota and cecal expression of chicken IL-1. Microbiota analysis
of chicken cecal tissue was performed using 16S rRNA gene amplicon sequencing. The microbiotas were compared between a
chicken group (8 animals) of FlaC-treated animals and 8 animals that were mock (PBS) treated. Shown are comparative numbers
of OTU (A), a comparison of the within-sample OTU diversity between the two groups (Shannon index) (B), and the comparative
family assignments of OTU present in the cecal microbiotas of the two groups (C). (D) A principal-coordinates analysis (PC; based
on Bray-Curtis distances [see Text S1 in the supplemental material]) of the microbiota data indicated that the chickens in the
FlaC-treated group (neon-green dots) have a significantly different microbiota composition than the chickens in the mock-treated
group (light-blue dots). Depicted in the graphs are the distances between the microbiota data in the first three dimensions (axes
PC 1 to PC 3) of the Bray-Curtis principal-coordinates analysis (distances between PC 1 and PC 2 in the left panel; distances
between PC 1 and PC 3 in the right panel), of which the first axis (PC 1) explains 30.2% of the total variance in the data set, the
second axis (PC 2) 26.4%, and the third axis (PC 3) 15.0%. For specific differences in the OTU assignments between the groups,
see Table 2. (E) Results of a quantitative RT-PCR of chIL-1 mRNA in cecal tissue of mock- and FlaC-treated chickens. Transcript
values were normalized against those of the chicken GAPDH transcript and are presented as absolute specific transcript amounts
in picograms (2 l of cDNA was used for each sample). Mean values and standard deviations from quadruplicate measurements
are shown. The significance of difference (Student’s t test, unpaired, one-sided) in cytokine expression between both groups is
indicated by an asterisk (*, P < 0.05).
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number of different ﬂagellin protein sequences from various species, we sought to
unravel sequence signatures in FlaC that might reveal something about its potential
function.
Remarkably, FlaC amino acid sequences from different Campylobacter and Helico-
bacter species appeared to be chimeras between primary sequences of ﬂagellins that
had earlier been reported to activate the innate immune system via TLR5 (Salmonella,
Pseudomonas) (9, 10) and sequences of other ﬂagellins, mainly those of the Epsilonpro-
teobacteria, that possess a low ability to elicit proinﬂammatory signaling via the TLR5
receptor (13–16). The conserved chimeric sequence nature of FlaCs was particularly
obvious in the N-terminal ﬂagellin D1 region (comprising amino acids 89 to 96) that has
recently been assigned by structural analysis of a heterotetrameric complex between
ﬂagellin and the ectodomain of TLR5 to be directly involved in TLR5 binding as “primary
binding interface B” (12). Galkin et al. had previously raised the hypothesis that the
three-dimensional structure of the monomeric ﬂagellins of nonstimulating bacterial
species seemed to have evolved by changing its surface in a way that preserves
multimeric ﬂagellar assembly and motility yet prevents TLR5 activation (17). We ob-
tained evidence under deﬁned conditions in vitro that FlaC can bind to human TLR5.
Structural studies of FlaC should clarify whether its fold and protein surface correspond
to those of the activating or to the nonactivating ﬂagellins and whether it is able at all
to form multimers. Our bioinformatic analysis provided further evidence that, while the
ﬂaC gene is present and conserved over a wide range of intestinal species of Epsilon-
proteobacteria, it is not linked to a ﬁxed gene neighborhood in the ﬂaC-containing
species. The function of the neighboring genes and their potential functional connec-
tion with FlaC are so far unknown.
In functional analyses, we sought to test the hypothesis that the FlaC ﬂagellin might
have evolved as an immunomodulatory protein. Since C. jejuni and other Campylobac-
ters naturally colonize different hosts, we used cell lines of human and avian (chicken)
origin for our analyses. FlaC activated the phosphorylation of MAP kinases p38 and ERK
in human and chicken cell lines, which is a characteristic downstream signal of TLR5
activation (34, 38). Cytokine release in human cells coincubated with FlaC was almost
negligible. Highly puriﬁed FlaC induced only minimal activation of NF-kB in both
human and chicken cells but was able to activate MAPK-dependent cytokine transcript
increases in human and chicken cells (both macrophage-like and epithelial cells). FlaC
activation potential seemed to be partial or reduced in comparison to that of the
canonical TLR5 agonist FliC. Chicken cells appeared to react more strongly to FlaC than
human cells. One established property of TLR ligands is their proinﬂammatory property
in acute infection or upon initial pathogen exposure (66, 67). FlaC appears to provide
only a partial proinﬂammatory activation potential to cells, which is directed mainly
toward MAP kinase activation and not toward NF-B activation or cytokine release from
cells. Thus, the FlaC signal might be primarily homeostatic and may lack certain features
TABLE 2 Designation of group-speciﬁc OTU signiﬁcantly different between microbiotas of FlaC-treated and mock-
treated chickens
Speciﬁcity and OTUa Class or order Family Genus (cluster)
Most closely related sequence
(% nucleotide identity)
Mock-treated group
OTU 63 Erysipelotrichales Erysipelotrichaceae Erysipelatoclostridium Clostridium innocuum (93)
OTU 73 Lactobacillales Lactobacillaceae Lactobacillus Lactobacillus ingluviei (98)
OTU 87 Clostridiales Clostridiaceae Clostridium (cluster IV) Clostridium sp. strain YIT12069 (100)
OTU 134 Clostridiales Oscillospiraceae Oscillibacter ND
FlaC-treated group
OTU 50 Erysipelotrichales Erysipelotrichaceae Clostridium (cluster XVIII) ND
OTU 52 Clostridiales Lachnospiraceae Blautia Blautia faecis (98)
OTU 121 Clostridiales Lachnospiraceae Blautia Blautia hydrogenotrophica (97)
aDesignation of group-speciﬁc OTU at the genus or species level was veriﬁed by nucleotide BLAST search of 16S rRNA gene amplicon
sequences using the NCBI nr database or SINA alignment with sequences listed in the Silva, Living Tree Project (LTP), or Ribosomal Database
Project (RDP) database (http://www.arb-silva.de). Noted identity scores (percentages) reﬂect similarities of OTU-speciﬁc consensus nucleotide
sequences with the identiﬁed closest bacterial relatives. ND, not determined due to low similarity (90%) of database hits.
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of other ﬂagellins, which remain to be explored. This may be attributable to the
chimeric ﬂagellin sequence of FlaC or to other, yet-unknown features of FlaC. Since a
high level of cellular cytokine release after TLR stimulation has been reported to be
dependent on a combination of multiple signals (68, 69) provided by some ﬂagellins,
e.g., by the canonical TLR5 ligand Salmonella Typhimurium FliC, through the combined
activation of TLR5 and the NLRC4 inﬂammasome (35) and possibly a third unknown
signal (70, 71), one of the next approaches will be to clarify whether FlaC is capable of
activating inﬂammasomes. Interestingly, it is just the region between amino acid
residues 89 and 96 of ﬂagellins, which was recently also shown to be also involved in
ﬂagellin adjuvanticity independently of TLR5 (71), that is highly conserved in different
FlaCs and shared with immune-activating ﬂagellins, such as FliC.
The secondary, mainly homeostatic, property of many TLR ligands (72), in addition
to their proinﬂammatory characteristics, has been characterized as a primary TLR-
mediated activation, followed by a quick downregulation of downstream signal trans-
duction from several TLRs within the ﬁrst 8 h after stimulation, which can be provided
by microRNA-mediated feedback silencing mechanisms involving IRAK1 or IRAK4 (47,
73). Homeostatic signaling can be mediated for instance by TLR5-activating ﬂagellins,
such as Salmonella FliC (20). It has also been shown that prior TLR5 stimulation provides
feedback inhibition against repeated TLR5 stimulation. Although not completely clar-
iﬁed, since only tumor necrosis factor alpha (TNF-) production, and not the secretion
of other cytokines, was tested as a readout in previous publications, TLR5 ligation, by
upregulation of microRNAs, may also promote cross-tolerance development against
the subsequent application of other TLR ligands (45, 46).
The property of cross-tolerization by FlaC may play a more important role in chronic
colonization than acute infection and immune defense. This may be of particular
relevance in the intestinal tract, where many other immune-activating or modulating
stimuli produced by a wealth of commensals and resident microbiota are present (55,
57) and where also Campylobacter may provide other, proinﬂammatory signals to the
host. Therefore, we tested the potential of puriﬁed C. jejuni FlaC to provide homeostatic
signaling and cross-tolerance induction, which might facilitate C. jejuni persistence in
the intestinal tracts of certain hosts in vivo. When FlaC was used as a ﬁrst stimulus on
human and chicken cells and the TLR4 ligand E. coli LPS was applied as a second
stimulus, FlaC, similarly to FliC, prevented or downmodulated secondary stimulation.
This downmodulation was time dependent and did not occur when FlaC and other
non-TLR5 stimuli were applied at the same time, suggesting that FlaC indeed is able to
provide a feedback mechanism against TLR stimulation. This ﬁnding suggests a mech-
anistic model by which FlaC might act predominantly as a homeostatic signal on
TLR-positive cells and might thereby provide an advantage in long-term or persistent
populations of the intestinal tract by Campylobacter and other gut-dwelling related
species. This proposed mechanism was also supported by our assays in which cells
were coincubated with live bacteria and lysates prepared from the C. jejuni wild type,
ﬂaC mutants, and a ﬂaC-complemented strain. In these tests, ﬂaC mutants led to a
signiﬁcantly increased stimulation of cells, in contrast to what occurred with the
wild-type bacteria, or vice versa, the supplementation or complementation of FlaC
decreased innate responses. Our data suggest that the activating potential of FlaC is
higher toward chicken than toward human cells. It is not yet possible to clarify whether
a host-speciﬁc difference regarding the downmodulation of proinﬂammatory signaling
or feedback silencing mediated by C. jejuni FlaC exists.
In vivo, when we administered even very small amounts of ultrapure FlaC to the
chicken intestine, this led to a signiﬁcant modulation of the intestinal microbiota
composition in the chicken cecum. This difference in composition, involving depletion
or enrichment of various species of the Lachnospiraceae family and the genera Clos-
tridium, Lactobacillus, Oscillibacter, and Blautia, was accompanied by a signiﬁcant
decrease in cytokine IL-1 expression in the ceca of the FlaC-treated birds in compar-
ison to levels in the mock-treated group. The signiﬁcant reduction in IL-1 expression
in the chicken cecum by FlaC, which again suggests that FlaC promotes homeostatic or
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cross-tolerance effects in the intestinal environment, may be due either to a direct
action of FlaC or to a combination of FlaC and the net outcome of an altered
microbiota. The timing and causality of events and the host-speciﬁc action of FlaC, as
well as in vivo infection experiments with C. jejuni (29), should be further addressed in
chickens.
Concluding remarks. Interestingly, C. jejuni and other campylobacters cause
chronic infection or colonization in avian, bovine, and porcine hosts; however, they only
rarely become persistent in humans, where they lead to an acute, severe, and self-
limiting infection. This study provided evidence that the Campylobacter-secreted ﬂagel-
lin FlaC, which is also present in other intestinal species, might be an important means
of providing limited, and potentially homeostatic, immune activation in the intestinal
tract. This activation may serve to modulate PRR-dependent responses that inﬂuence
the interplay between the host innate immune system in the intestinal tract, the
resident microbiota, and the sequence of events during acute or persistent Campylo-
bacter infection. The question of whether FlaC plays a role in these two differential
outcomes of host interaction by affecting TLR-dependent or other innate immune
responses differently in different host species in vivo remains to be answered. In
addition, both C. jejuni (74) and S. enterica (75) have recently been described to proﬁt
from a proinﬂammatory environment in the intestinal tract to successfully compete for
nutrients with the resident microbiota, for instance by favoring the production and
metabolic use of tetrathionate and other microbiota-derived metabolites. Since other
microbe-associated molecular patterns of C. jejuni have evolved to be rather evasive
toward innate immune recognition (15, 16, 76), the activation potential of FlaC,
although apparently of a limited nature, may contribute to gaining a competitive edge
in intestinal colonization and persistence by inducing both proinﬂammatory and
homeostatic signals.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Campylobacter jejuni strains NCTC 11168 (ATCC 700819) and
81-176 (77) were used. C. jejuni cultures were grown at 37°C or 42°C under microaerobic conditions (10%
CO2, 5% O2, 85% N2) in vented jars or under anaerobic conditions (10% CO2, 10% H2, 80% N2) in a
Scholzen incubator on blood agar plates (blood agar base II; Oxoid, Wesel, Germany), supplemented with
10% deﬁbrinated horse blood (Oxoid) and standard antibiotics (10 mg/liter vancomycin, 3.2 mg/liter
polymyxin B, 5 mg/liter trimethoprim, 4 mg/liter amphotericin B), or in brain heart infusion broth (Oxoid)
with the addition of 2.5 g/liter yeast extract (Merck, Darmstadt, Germany). The C. jejuni mutant strains
were grown on blood agar plates with standard antibiotic supplement and 20 mg/liter chloramphenicol
for selection. For coincubation assays with eukaryotic cells and for bacterial lysate preparations (ultra-
sonicated), bacteria were grown on plates for approximately 24 h before being harvested. Escherichia coli
strains DH5 and MC1061 were used for cloning. For the overexpression of proteins, the E. coli strain
BL21(DE3) was used. E. coli was cultured in Luria-Bertani (LB) broth (Difco LB agar; Lennox, BD
Biosciences, Heidelberg, Germany) or on LB plates containing 1.5% Bacto agar. When appropriate,
ampicillin (500 mg/liter) or kanamycin (20 mg/liter) was added to the medium.
Cell types and culture conditions. Different cell lines were used for cell coincubation and trans-
fection assays. Human embryonic kidney 293 cells (HEK293T) were used for transfection and expression
of recombinant proteins and cultured in Dulbecco’s minimal essential medium (MEM) (Biochrom, Berlin,
Germany) supplemented with 10% (vol/vol) fetal bovine serum (FBS). The HD-11 chicken macrophage-
like cell line and the human monocytic cell line THP-1 were maintained in Iscove’s basal medium (IBM)
(Biochrom) supplemented with 10% (vol/vol) FBS. The Lovo human colon epithelial cell line (78) was
cultured in Dulbecco’s MEM and Ham’s F-12 (1:1 mixture) (Biochrom) supplemented with 10% (vol/vol)
FBS. HD-11, THP-1, and Lovo cell lines stably transfected with the ﬁreﬂy luciferase gene under the control
of an NF-B promoter were continuously cultured in the presence of puromycin (5 g/liter). All cell lines
were routinely kept at 37°C in a 5% CO2 humidiﬁed atmosphere. Surface expression of TLR5 in THP-1 cells
was veriﬁed by ﬂuorescence-activated cell sorting (FACS) as previously published (79). Expression of tlr5
mRNA in chicken HD-11 cells has been previously shown (80), and we have conﬁrmed the presence of
the tlr5 transcript by semiquantitative reverse transcription-PCR (RT-PCR) in all cell lines used (not shown),
except for Lovo cells. The functional activity of TLR5 was conﬁrmed for all cell lines by ultrapure FliC
stimulation and positive measurement of IL-8 secretion.
Generation of ﬂaC mutants by allelic exchange and complementation of ﬂaC. ﬂaC mutants and
ﬂaC complementation strains in C. jejuni were generated by an allelic-exchange gene replacement
strategy. Brieﬂy, the ﬂaC gene from strain 11168 was PCR ampliﬁed using primers CjﬂaC_F_BamHI and
CjﬂaC_R_BamHI (Table 3) and cloned into pUC18. A unique internal BglII restriction site in the ﬂaC gene
was used to insert the chloramphenicol resistance cassette (CAT), derived from the plasmid pBHpC8 (81).
The plasmid containing interrupted ﬂaC was used for the natural transformation of two C. jejuni strains,
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11168 and 81-176, and chloramphenicol-resistant clones were recovered after 3 days. The ﬂaC mutant of
the C. jejuni strain 81-176 was complemented by allelic gene replacement of ﬂaC in the rdxA locus
together with a gentamicin (Gm; aminoglycoside acetyltransferase, aac) resistance cassette from
pUC1813apra (82). The rdxA gene from strain 81-176 was PCR ampliﬁed using primers CjrdxA_XbaI_F1
and CjrdxA_XbaI_R1 (Table 3) and cloned into pUC18 (Table 4). An internal BglII restriction site in the rdxA
gene was used to insert ﬂaC from strain 11168. This construct was ampliﬁed via inverse PCR using primers
CjrdxA_SpeI_F3 and CjrdxA_ClaI_R3 (Table 3) and served for the insertion of the PCR-ampliﬁed Gm
cassette (with primers Gm1_ClaI and Gm2_SpeI [Table 3]; template, the pUC1813apra plasmid) upstream
of ﬂaC using ClaI and SpeI restriction sites. The correct insertions after allelic exchange in CAT- or
Gm-resistant clones recovered after natural transformation was conﬁrmed by PCR using different primer
combinations. The mutants and complementants showed no growth difference from the wild type in
growth curve experiments (not shown). FlaC expression of the complementation strains was veriﬁed by
Western blotting (not shown).
Plate motility assay. The motility of C. jejuni wild-type strains and the corresponding ﬂaC mutants
and complemented strains was tested in a six-well plate format with semisolid medium, containing 2.8%
(wt/vol) brucella broth (BD Biosciences), 0.3% (wt/vol) Bacto Agar (BD Biosciences), 5% (vol/vol) heat-
inactivated horse serum (Gibco, Darmstadt, Germany), and standard antibiotics (see above). Bacteria
were grown overnight on blood agar plates, adjusted to a ﬁnal optical density at 600 nm (OD600) of 1.00,
and inoculated with a pipette tip into the center of motility agar wells. The plates were then cultured for
2 days at 37°C under microaerobic or anaerobic conditions in a Scholzen incubator, and the swim
diameter in the agar after the incubation was measured in comparison to a negative control (C. jejuni ﬂgR
mutant).
DNA and protein methods. DNA methods were performed according to standard protocols (83)
using enzymes produced by New England Biolabs (NEB, Ipswich, NJ), Invitrogen (Carlsbad, California), or
Roche (Basel, Switzerland). DNA from bacteria or tissue was prepared using the Qiagen Tissue Amp kit
according to the manufacturers’ instructions, with slight modiﬁcations. PCRs were performed using Taq
polymerase (Roche) or Phusion polymerase (NEB), if products with high ampliﬁcation accuracy were
required. Sanger sequencing technology was applied for sequencing of the cloned plasmids. Protein
TABLE 3 Oligonucleotides used for gene ampliﬁcation and cloning
Gene Primers Sequence (5=–3=)a Tm (°C) Reference
ﬂaC (Cj0720c) CjﬂaC_F_BamHI AAAGGATCCCAAAGTGGCTTAATGATGACG 55 This study
CjﬂaC_R_BamHI AAAGGATCCCGCTAGAGCTTGGACTTGAT 55 This study
CjﬂaC_F3 AAAGGATCCATCTCTGATGCAACTATGATG 53 This study
CjﬂaC_R2 AAACTCGAGTTGTAATAAATTAGCAATTTTGC 51 This study
rdxA (Cjj81176_1083) CjrdxA_ClaI_R3 AAAATCGATGTTGATTGTAACATAGGGTTG 51 This study
CjrdxA_SpeI_F3 AAAACTAGTCAAGTGCGAGTCATAATATC 51 This study
CjrdxA_XbaI_F1 AAATCTAGAGTGATTTTGTCGTAGATGAAG 53 This study
CjrdxA_XbaI_R1 AAATCTAGATATAAATTTCCAAGGTTCCA 51 This study
SalTy LT2 ﬂiC SalLT2FliCBamHI(F) CGGGATCCATGGCACAAGTCATTAATAC 49 This study




chTLR5_R1 AAAAGCGGCCGCCGTGTGAGACTGTCGCTATAGTTTG 69 This study
CAT cassette pCAT1 AACAGCTATGACCATGATTAC 57 81
pCAT2_BamHI AGAGGATCCGATATCGCATGCCTGCAGAG 57 81
Gm cassette (aac) Gm1_ClaI AAAATCGATCGGGTGACTAACTAGGAGGAATAA 65 This study
Gm2_SpeI AGAACTAGTCCGTGTCATTATTCCCTCCAGGTA 67 This study
aRestriction sites in oligonucleotides are underlined. Tm, melting temperature.
TABLE 4 Plasmids used in this study
Plasmid Vector Description Resistancea Reference or source
pEF6-hTLR5 pEF6-V5 Protein expression vector for human TLR5 Ampr 86
pEF6-V5 Mammalian protein expression vector, originated from pEF6-TLR5-V5 by
excision of the insert, EF-1 promoter, V5 tag
Ampr 13
pCJ801 pEF6-V5 Protein expression vector for chicken TLR5 (pEF6-chTLR5-V5) Ampr E. Faber and C. Josenhans,
unpublished data
pET28a Protein expression vector, T7 lac promoter, 6His tag, T7 tag Kmr Novagen, Darmstadt,
Germany
pCJ375 pET28a S. enterica serovar Typhimurium LT2 ﬂiC cloned into pET28a via BamHI
and XhoI
Kmr S. K. Lee and C. Josenhans,
unpublished data
pCJ1024 pET28a ﬂaC (C. jejuni, strain NCTC 11351) cloned into pET28a via BamHI and XhoI Kmr This study
pCJ1025 pUC18 ﬂaC::Cm (C. jejuni strain 11168) Ampr Cmr This study
pCJ1405 pUC18 rdxA::Gm (C. jejuni strain 81-176)  ﬂaC (C. jejuni strain 11168) Ampr Gmr This study
aAmpr, ampicillin resistance; Kmr, kanamycin resistance; Cmr, chloramphenicol resistance; Gmr, gentamicin resistance.
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amounts were determined by bichinchoninic acid (BCA) protein assay (Thermo Scientiﬁc, Pierce, Rock-
ford, IL), and protein analysis was performed by separation on denaturing 12% sodium dodecyl sulfate
(SDS) polyacrylamide gels and Western immunoblot detection according to standard methods (84). Equal
amounts of protein were loaded in each lane of the gels. Antibodies for labeling were used as indicated
in the results. Visualization of immuno-reactive bands was obtained using the Super Signal West
Pico chemiluminescent substrate (Pierce, Thermo Scientiﬁc, Bonn, Germany) and enhanced-
chemiluminescence (ECL) hyperﬁlm (GE Healthcare, Piscataway, NJ). Analysis of phosphoproteins (P-p38,
anti-P-p38 antibody, rabbit 92115; Cell Signalling Technology; used at a 1:1,000 dilution) of coincubated
cells was performed on Western blots from cleared cell lysates prepared in radioimmunoprecipitation
assay (RIPA) buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA,
protease inhibitor cocktail Complete [Roche], phosphatase inhibitor cocktail PhosStop [Roche]). Anti-p38
MAPK antibody (rabbit 92125; Cell Signalling Technology) was used on the same blots as a control for
total p38. Quantiﬁcation of chemiluminescent signals for the P-p38 blots was performed by densito-
metric measurements using the software ImageJ (http://rsb.info.nih.gov/ij/) and normalizing against
signal intensities in each lane obtained using the p38 antibody. Additional normalization was performed
against the corresponding loading controls visualized with the aid of anti-actin antibody (Chemicon
MAB1501; mouse monoclonal antibody; used at a 1:2,000 dilution). In the case of sequential antibody
application, membranes were stripped with Restore Western blot stripping buffer (Thermo Scientiﬁc,
Pierce).
Lysis and fractionation of C. jejuni. C. jejuni lysates were generated by resuspending bacteria grown
on blood agar plates in an appropriate volume of 0.9% NaCl and lysing by sonication (Branson Soniﬁer
450). To separate the soluble (cytoplasmic) and insoluble (membrane-associated) fractions of bacteria,
C. jejuni lysates were centrifuged for 20 min at 9,000  g and 4°C. The pellet, enriched for membrane-
associated proteins, was resuspended in an appropriate volume of 0.9% NaCl; the supernatant repre-
sented the soluble bacterial fraction. For the preparation of secreted proteins, C. jejuni was grown in
liquid culture to a deﬁned OD600 of 0.4 to 0.6. Bacteria were harvested by centrifugation for 20 min at
9,000  g. Subsequently, the supernatant, which contains secreted proteins, was ﬁltered through a
0.22-m-pore-size sterile ﬁlter (polyethersulfone [PES] membrane, Millipore Express; Millex GP, Schleicher
& Schuell). Precipitation of secreted proteins was conducted with trichloroacetic acid (TCA) overnight at
room temperature, followed by centrifugation for 15 min at 14,000  g and 4°C and a ﬁnal washing step
with ice-cold 100% acetone. Secreted proteins were resuspended in modiﬁed SDS-PAGE loading buffer
(20% [vol/vol] 5 SDS-PAGE loading buffer, 25% [vol/vol] Tris-HCl [1 M, pH  8.0] in distilled water). For
enriching surface-associated proteins, which contain, among others, ﬂagellar proteins, C. jejuni was
grown on blood agar plates for 2 to 3 days. Bacteria were resuspended in 0.9% NaCl, and proteins were
sheared off the bacterial surface by repeatedly (up to 30 times) pushing the suspension through a
23-gauge needle. Sheared-off material was separated from bacterial cells by differential centrifugation
steps: 20 min at 9,000  g and ultracentrifugation for 1 h at 40,000  g (Beckman Optima100
ultracentrifuge) and 4°C. Surface-associated proteins were resuspended in Tris buffer (100 mM Tris-HCl,
pH 7.5). All bacterial fractions were analyzed on Western blots using anti-FlaC antiserum and respective
fractionation controls (not shown).
Recombinant expression and puriﬁcation of C. jejuni FlaC and S. enterica serovar Typhimurium
FliC. For recombinant expression of C. jejuni protein FlaC in E. coli, the FlaC expression plasmid pCJ1024
(Table 4) was constructed, using primers CjFlaC_F3 and CjFlaC_R2 (Table 3), and transformed into E. coli
BL21(DE3). Expression of FlaC was induced at early exponential phase (OD600  0.6) by adding 0.5 mM
isopropyl-D-thiogalactopyranoside (IPTG). Bacteria were harvested after they reached the stationary
phase (4 to 5 h), resuspended in appropriate volumes of lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 5 mM
MgCl2), and lysed by sonication. To separate the soluble from the insoluble fraction, the whole-cell lysate
was centrifuged for 20 min at 9,000  g and 4°C. The recombinantly expressed FlaC contained 6His
tags on its C and N termini and was puriﬁed from the soluble bacterial fraction by afﬁnity chromatog-
raphy using Ni2-nitrilotriacetic acid (NTA)-Sepharose beads (Qiagen, Hilden, Germany) under denaturing
conditions. The puriﬁcation procedure comprised several wash steps with buffer B (8 M urea, 100 mM
NaH2PO4, 100 mM Tris-HCl, pH 8.0) and buffer C (6 M urea, 100 mM NaH2PO4, 20 mM Tris-HCl, pH 6.3),
with decreasing pH. Elution of the protein was achieved by using buffers with further decreased pH:
buffer D (6 M urea, 100 mM NaH2PO4, 20 mM Tris-HCl, pH 5.8) and buffer E (6 M urea, 100 mM NaH2PO4,
20 mM Tris-HCl, pH 4.5). The single fractions were analyzed by SDS-PAGE with respect to their FlaC
content; selected elution fractions were pooled and dialyzed against at least three changes of PBS using
a dialysis chamber (Slide-A-Lyzer, molecular weight cutoff [MWCO], 3,500; Thermo Scientiﬁc). For
coincubation experiments of eukaryotic cells with puriﬁed FlaC, an additional puriﬁcation step by elution
of the protein from an SDS gel in an Electro Eluter (model 422; Bio-Rad, Munich, Germany) was
performed. Eluted protein was again dialyzed several times against cell culture-grade PBS, using
pyrogen-free microconcentrator tubes (MWCO, 10,000; Amicon ﬁlter devices; Millipore) for centrifugation
at 8,000  g and 4°C. Expression and puriﬁcation of Salmonella ﬂagellin FliC was performed accordingly.
The purity and amounts of ultrapure recombinant ﬂagellins were ﬁnally checked on silver- or Coomassie
blue-stained SDS gels (Fig. S7). Limulus assays (Limulus amebocyte lysis [LAL] chromogenic endpoint
assay; Cambrex) of recombinant ﬂagellins prepared by this method did not detect LPS above the
detection limit of 1 endotoxin unit (EU) per g of protein (13), and the preparations can thus be
considered virtually free of contaminations by other TLR ligands. Before coincubation with cells, ﬂagellar
preparations were diluted in 1 PBS (cell culture grade) and monomerized by ultrasonication for 1 min.
In cell activation experiments, the protein nature of the activating principle (puriﬁed FlaC) was again
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veriﬁed by heat-treating the protein preparations as a control, which led to a complete loss of activity
(not shown).
Generation of antiserum against C. jejuni FlaC. An antiserum raised against the recombinantly
expressed and puriﬁed FlaC from C. jejuni was generated in rabbits by repeated intradermal injection in
combination with Freund’s adjuvant (BioGenes, Berlin, Germany).
Anti-His tag pulldown assay. To investigate protein-protein interactions, pulldown analysis was
performed. Two milligrams of puriﬁed recombinant 6His-FlaC–6His per sample was incubated
for 30 min at 4°C with a 20-l slurry of Cobalt (Co2) beads (Talon beads; BD Biosciences) under
continuous mixing in RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM
EDTA, 1 mM EGTA, protease inhibitor cocktail Complete [Roche], phosphatase inhibitors). An
incubation step with cleared lysates (soluble fraction) of TLR5-V5 plasmid-transfected HEK293T cells
(200 g of lysate per sample) was performed, followed by coincubation for 1 h at 4°C under
continuous mixing. After unbound protein was removed by stringent wash steps with imidazole-
containing buffer (60 to 80 mM imidazole in PBS), the beads were resuspended in appropriate
volumes of 2.5 SDS-PAGE loading buffer, and protein interactions were analyzed on Western blots.
Precipitated TLR5 was detected using an antibody against the C-terminal V5 epitope tag (mouse
monoclonal R960-25; Invitrogen Life Technologies).
Cell transfection with plasmid DNA and protein expression analysis. HEK293T cells, which were
seeded in 24-well plates, were used for transfection experiments at 80% conﬂuence. One hour before
transfection, the medium was changed to 0.5 ml OptiMEM medium (Gibco) containing 5% fetal calf
serum (FCS). The plasmid of interest (0.4 mg), which was prepared with an endo-free plasmid midi-kit
(Qiagen, Hilden, Germany), was transfected using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. To allow expression of transfected constructs, cells were further incubated
for 24 h to 48 h before being harvested. Protein expression was then analyzed by Western immuno-
blotting.
Coincubation of eukaryotic cells with proteins or live C. jejuni strains. For coincubation exper-
iments with live C. jejuni strains or puriﬁed proteins, cells were seeded into 96 (4  104 cells in 100 l
per well)-, 24 (2  105 cells in 1 ml per well)-, or 6 (2  106 cells in 3 ml per well)-well plates 24 h prior
to the infection. Media were replaced 30 min before the coincubations. For bacterial coincubations, cells
were infected with freshly resuspended bacteria at an MOI of 10, 20, 25, or 50 and synchronized by
centrifugation (300  g, room temperature, 10 min). Equal bacterial amounts at the endpoint of cell
coincubation with live C. jejuni bacteria were veriﬁed by Western immunoblotting using an anti-C. jejuni
antiserum produced in rabbits.
In order to test the activation potential of protein preparations, cells were coincubated with different
amounts of sonicated proteins (ultrapure ﬂagellins) for 3 to 4 h, and a 96-well plate format was used for
determining NF-B activation of stable luciferase reporter cells. NF-B-mediated luciferase activation was
measured using SteadyGlow ﬁreﬂy luciferase substrate (Promega Inc., Madison, WI) in a Victor3 Wallac
1420 microtiter plate luminometer (GE Healthcare). The 24-well plate format was chosen for transfection
experiments or for the further quantitative analysis of cytokine secretion (IL-8) or P-p38 analysis after
coincubation with ultrapure proteins, live bacteria, or bacterial lysates. Equal MOIs were used to compare
live bacteria between different strains; for cell coincubation with bacterial lysates, equal protein amounts
of each lysate (BCA assay) were used for the different strains.
For assaying TLR4 speciﬁcity, polymyxin B (Sigma Aldrich) was added to the cells 1 h prior to starting
the further incubation steps. For the 2-day experiments assessing tolerization against cell activation by
E. coli LPS (TLR4 ligand ultrapure grade, from E. coli O111:B4; List Biological Laboratories Inc., Campbell,
CA), THP-1 or HD-11 cells (2 104 per well) were incubated in 96-well plates. One day after being seeded,
the cells were activated by adding proteins or activation controls, respectively. Three hours and 19 h after
the primary activation, NF-kB-dependent luciferase activity was determined using Promega SteadyGlo
luciferase buffer in selected wells. At this time point, ultrapure LPS was added as a secondary stimulus
in the remaining experiment wells and incubated for a further 3-h period, followed by the last luciferase
measurement. For all experiments and conditions involving LPS, the ultrapure LPS preparation was used.
IL-8 in supernatants of cell activation experiments was routinely determined using a commercially
available ELISA (IL-8 OptEIA ELISA system; Becton, Dickinson, Inc., BD Biosciences), according to the
manufacturer’s instructions. Coincubation experiments using a 6-well plate format were performed for
RNA preparations and real-time PCR analysis.
RNA preparation and real-time PCR. For RNA preparation, cell pellets were resuspended in Qiagen
RNeasy lysis buffer containing -mercaptoethanol and transferred to lysing matrix D tubes containing
ceramic beads (MPbio, Germany). The cells were lysed in a bead beater machine (FastPrep; Bio101
Thermo Scientiﬁc, Bonn, Germany) for 45 s. The RNA was further puriﬁed using the Qiagen RNeasy minikit
according to the manufacturer’s instructions. Total RNA was quantitated in a NanoDrop 1000 device
(Thermo Scientiﬁc, Bonn, Germany), and equal amounts of each sample were subjected to DNase I
treatment (Roche). The residual content of DNA was determined by PCR using chicken glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) primers for HD-11 cells and human GAPDH primers for THP-1 and
Lovo cells. If necessary, the residual DNA was removed by a second DNase I treatment and subsequent
RNeasy column cleanup. cDNA was prepared from equivalent amounts (1 g) of total RNA using
Superscript III reverse transcriptase (Invitrogen) and oligo(dT) primers (Invitrogen) according to the
manufacturer’s instructions.
Quantitative RT-PCR was performed using SYBR green mix (Qiagen) on equal amounts of cDNA (1 to
2 l) and normalized to the results of a corresponding GAPDH or 16S rRNA gene control reaction mixture
prepared from the same cDNAs (primers used for RT-PCR are listed in Table S2 in the supplemental
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material). Reactions were carried out in a Bio-Rad thermocycler (Bio-Rad C1000/CFX96 combined system
[Bio-Rad, Hercules, CA]). Cycling conditions were as follows: denaturation for 10 min at 95°C and
ampliﬁcation for 40 cycles at 95°C for 15 to 45 s, at 59°C (or optimized according to the calculated
annealing temperature of the primer pairs) for 15 s, and at 72°C for 30 s. For quantiﬁcation of DNA
amounts, a serial standard was prepared from a puriﬁed PCR product of the gene of interest. Each
reaction was performed in triplicate.
Experimental administration of puriﬁed FlaC into SPF chicken and microbiota analyses. SPF
eggs from white SPF Leghorn layer chickens were purchased from Valo BioMedia GmbH (Bremen,
Germany). After hatching, birds were kept jointly in metal cages without bedding and supplied with
conventional, autoclaved feed and water ad libitum. Two weeks after hatching, the birds were separated
into two groups consisting of 8 animals each and further kept in two separate closed cages in the same
room. At this time point, one group of birds received 25 g of puriﬁed recombinant FlaC in 200 l sterile
cell culture-grade PBS via intracloacal administration. The mock-treated group was given 200 l of only
sterile PBS by the same route. The application of puriﬁed FlaC (25 g) or PBS (control group) via the same
route was repeated after 7 and 10 days. Fourteen days after the initial administration, birds were
sacriﬁced and their organs (liver, cecal tonsils, and right-hand cecum after gentle removal of contents)
collected for CFU determination of culturable bacteria. The complete left-side ceca and three different
gut sections of each bird were cleared of contents and ﬁxed in 4% paraformaldehyde (PFA) for
histopathological analysis. Two tissue samples of the tips of each right-hand cecum were sampled and
stored in RNA-Later (Qiagen) at 20°C for further RNA preparation and at 18°C for DNA isolation and
subsequent microbiota analyses, respectively. Animal experiments were conducted according to the
German animal protection laws and approved by the federal authorities (LAVES, Lower Saxony, Germany)
under the administrative identiﬁcation number 33.14-42502-04-13/1282. Microbiota analysis by 16S rRNA
gene amplicon sequencing from total chicken cecal tip tissue DNA was performed using PCR products
of primer pairs covering the bacterial 16S rRNA gene variable regions V1 to V3 on a Roche 454 GS FLX
pyrosequencing platform (85). Microbiota sequence reads were analyzed as previously described, with
modiﬁcations (85; detailed in Text S1 in the supplemental material).
Nucleotide sequence accession number. The microbiota data (16S rRNA gene sequences) are
available under accession number PRJEB11550 (European Nucleotide Archives ENA at EMBL-EBI).
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